Impact of continuous serratus plane analgesia on quality of recovery after video-assisted thoracic surgery: a prospective double-blind, randomized, placebo-controlled trial
Listen to this summary
The authors aimed to determine whether continuous serratus anterior plane block (SAPB) infusion, combined with multimodal analgesia, could enhance the quality of recovery (QoR-40) after video-assisted thoracoscopic surgery (VATS). Although the SAPB group showed higher QoR-40 scores and reduced opioid consumption compared to the control group, these differences were not statistically significant for the primary outcome. The study concludes that while continuous SAPB may have some benefits, larger trials are needed to confirm its impact on patient-reported recovery.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Regional anesthesia and pain medicine
View all →Jun 11, 2026 · Regional anesthesia and pain medicine
Novel ultrasound-guided rotator cuff interval injection using the biceps long-axis approach: a cadaveric study
Jun 10, 2026 · Regional anesthesia and pain medicine
Transcriptomic decoding of dynamic brain activity alterations in chronic non-specific low back pain
Jun 10, 2026 · Regional anesthesia and pain medicine
National patterns and variation in regional anesthesia use for shoulder, hip, knee, and ankle arthroplasty: a National Inpatient Sample analysis
More in Anesthesiology
View all →Jun 24, 2026 · Journal of addiction medicine
Trends in Public Opinion About US Illicit Drug Policy: Results From the 2000 to 2025 Gallup Survey
Jun 24, 2026 · Journal of addiction medicine
Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant
Jun 24, 2026 · Critical care medicine
Ethical Implications of the Slow Code: A Systematic Review of Ethics of Slow Codes in U.S. Hospitals
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · Journal of addiction medicine
Medicaid Prior Authorization and Discontinuation of Buprenorphine
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


